Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big ...

Biotech firm Bio-Techne missed its first-quarter revenue estimates on Wednesday, hurt by sluggish demand for its products amid soft biotech funding environment in China.

Investors have once again turned to Chinese pharmaceutical company Jiangsu Hengrui to create a new biotech startup, this time ...

Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look ...

Frontier’s Wilmington hub will anchor North American operations, with Shannon, Ireland, leading efforts in Europe, the Middle ...

Sun Pharma is open to expanding its US manufacturing capabilities in response to the Trump administration's 100% tariff on ...

The quarter saw Amgen lift its total revenue by 12% year over year to $9.6 billion, fueled by double-digit increases in the ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...

Equities broadly ended higher, with some reaching record levels, contributing to strong year-to-date performance. Read more ...

Google’s parent company received a relatively benign antitrust ruling that would not force Alphabet to sell its Chrome ...